Table 3. Odds ratio and 95% CIs for the presence of glaucoma.
Crude model | Model 1† | Model 2‡ | |
Diabetes | |||
HbA1c or fasting glucose * | 3.99 (2.05, 7.76) | 2.09 (1.11, 3.92) | 1.80 (0.93, 3.47) |
Fasting glucose only § | 3.83 (2.24, 6.55) | 2.28 (1.37, 3.81) | 2.12 (1.23, 3.67) |
HbA1c only † | 4.52 (2.65, 7.68) | 2.65 (1.49, 4.71) | 2.10 (1.19, 3.71) |
Prediabetes | |||
HbA1c or fasting glucose * | 1.36 (0.72, 2.56) | 0.96 (0.52, 1.75) | 0.88 (0.45, 1.75) |
Fasting glucose only § | 1.23 (0.75, 2.02) | 1.02 (0.63, 1.66) | 1.01 (0.57, 1.82) |
HbA1c only † | 2.63 (1.53, 4.51) | 1.72 (0.98, 3.05) | 1.57 (0.85, 2.92) |
Metabolic syndrome | 1.50 (0.98, 2.29) | 1.30 (0.83, 2.03) | 1.13 (0.60, 2.16) |
Elevated waist circumference | 1.31 (0.91, 1.90) | 1.19 (0.81, 1.75) | 0.89 (0.55, 1.45) |
Elevated blood pressure | 2.47 (1.71, 3.56) | 1.38 (0.97, 1.97) | 1.39 (0.92, 2.09) |
Elevated triglyceride | 0.99 (0.59, 1.68) | 1.09 (0.65, 1.81) | 0.90 (0.52, 1.57) |
Reduced HDL | 0.69 (0.40, 1.18) | 0.83 (0.47, 1.47) | 0.73 (0.35, 1.52) |
Elevated fasting glucose | 1.95 (1.40, 2.70) | 1.35 (1.00, 1.83) | 1.29 (0.85, 1.95) |
Diabetes duration >5 years | 2.48 (1.06, 5.76) | 2.20 (1.02, 4.73) | 3.90 (1.63, 9.32) |
Insulin resistance || | 1.19 (0.78, 1.81) | 1.22 (0.78, 1.90) | 1.14 (0.64, 2.01) |
Adjusted for age, gender, and ethnicity.
Further adjusted for smoking, physical activity, alcohol intake, education, and BMI.
*Diabetes defined as self-report, HbA1c ≥6.5%, fasting glucose ≥126 mg/dL, or taking diabetic medications.Pre-diabetes defined as self-report, HbA1c ≥5.7% to <6.5%, or fasting glucose ≥100 mg/dL to <126 mg/dL.
Diabetes defined as self-report, HbA1c ≥6.5%, or taking diabetic medications. Pre-diabetes defined as self-report or HbA1c ≥5.7% to <6.5%.
Diabetes defined as self-report, fasting glucose ≥126 mg/dL or taking diabetic medications. Pre-diabetes defined as self-report or fasting glucose ≥100 mg/dL to <126 mg/dL.
Values are based on the subsample of participants not taking insulin or medication for diabetes.